revious reports have demonstrated that myocardial microvascular damage is related to left ventricular (LV) dysfunction in patients with heart failure. 1,2 LV contractile dysfunction is associated with an increased incidence of morbidity and mortality in patients with heart failure, 3,4 so it is important for the optimum treatment of patients with heart failure to assess any myocardial microvascular damage in detail. A recent study used positron emission tomography to demonstrate that myocardial perfusion abnormalities occur in patients with idiopathic dilated cardiomyopathy (IDC); 5 however, there is the clinical issue of the inability to perform repetitive testing with this technique.
Methods

Study Population
Thirty-five patients with IDC were enrolled. All patients underwent conventional coronary angiography, which revealed a normal epicardial coronary artery. Patients with secondary dilated cardiomyopathy were excluded. Symptoms and clinical signs of congestive heart failure were controlled at the start of the study by oral treatment with a combination of diuretics, angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers, and -blockers. Cardiac events were defined as sudden cardiac death or hospitalization for the progression of congestive heart failure. Ten age-matched healthy subjects who showed no evidence of organic cardiac disease and no cardiac dysfunction were included as the control group. All patients gave informed consent to participate in the study.
Conventional and Intravenous Myocardial Contrast Echocardiography
A skilled echocardiographer without knowledge of the clinical features of the patients performed the echocardiographic study using a SONOS 5500 ultrasound system (Philips Medical Systems). LV end-diastolic volume index (EDVI), LV end-systolic volume index (ESVI) and LV ejection fraction (LVEF) were calculated using the modified Simpson method according to the recommendations of the American Society of Echocardiography. 9 MCE was performed using the apical 4-and 2-chamber views with an S3 transducer that transmitted ultrasound at a mean frequency of 1.3 MHz and received it at a mean frequency of 3.6 MHz (ultra-harmonics). The mechanical index, overall gain, compression, depth and focus were kept constant during the entire protocol. After pre-contrast images were acquired, the intravenous contrast agent, Levovist™ (Schering AG, Berlin, Germany) was infused continuously by a pump at a rate of 90-120 ml/h. The infusion rate was adjusted in each patient to acquire adequate myocardial enhancement at every sixth cardiac cycles with minimal attenuation. To accurately judge both the time for a steady state to be reached after initiating the infusion and the infusion rate, we visually assessed the absence of any change in myocardial contrast intensity over 3 successive frames as described by Wei et al. 7 After a steady state was achieved (approximately 2 min after the initiation of infusion), repeat MCE imaging was started with 1:6 pulsing intervals during end-systole and the images acquired online were stored on optical disk for later quantification. The perfusion territory of interest was positioned as much as possible in the center to prevent false-negative myocardial opacification because of poor lateral resolution. Background-subtracted myocardial contrast intensity at 1:6 pulsing intervals, which reflects peak myocardial contrast intensity (PMCI) and myocardial blood volume, was measured on myocardial territories of interest over 3 successive frames and each set of data was averaged. In order to minimize the variability of myocardial contrast in each segment, the PMCI was calibrated by the peak intensity of the adjacent left ventricle as follows: calibrated PMCI = myocardial PMCI -peak contrast intensity of the adjacent left ventricle (dB). 10, 11 Regions of interest were located on the mid-septal wall and mid-lateral wall in the apical 4-chamber view, and on the inferior wall in the apical 2-chamber view. Calibrated PMCI data from different myocardial segments were averaged. In addition, using a cuff sphygmomanometer, the resting arterial blood pressure was measured before the echocardiographic study.
Myocardial Thallium-201 Single Photon Emission Tomography
Myocardial thallium-201 single-photon emission tomography was performed at rest as the standard modality of myocardial perfusion, as previously described. 12 Ten minutes after the administration of 111 MBq of thallium-201, the initial images at rest were produced, and the delayed images were acquired 5 h later. The extent score (ES) was calculated by quantitative analysis as the value of the myocardial perfusion defect, according to the method of Garcia et al. 13 
Measurement of Neurohumoral Factors
After bed rest for at least 30 min, we collected peripheral blood samples in chilled tubes and immediately centrifuged them at 4°C. The plasma was frozen and stored at -80°C for radioimmunoassay. We measured the plasma concentrations of norepinephrine (NE) and brain natriuretic peptide (BNP) in all subjects, as previously reported. 14 
Statistical Analysis
Continuous data were expressed as mean ± SD. Comparisons between control subjects and patients with IDC were made using the Mann-Whitney U rank-sum test. All correlations were made with linear regression analysis. Univariate and multivariate Cox's proportional-Hazards regression models were conducted to evaluate univariate as well as independent associations with cardiac events with IDC patients. In addition, the event-free survival for the patients was estimated using the Kaplan-Meier method, and statistical difference between subgroups was assessed using the log rank test. Differences were considered significant at p<0.05. Interobserver and intraobserver variabilities of the MCE analysis were assessed in 15 random patients by 2 independent observers and by a single observer on 2 separate occasions. Interobserver and intraobserver variability for quantification of calibrated PMCI was r=0.82, p<0.01 and r=0.85, p<0.01, respectively.
Results
Patient Characteristics
The clinical characteristics of the control subjects and patients with IDC are listed in Table 1 . There were no significant differences in age, gender, or body surface area between the 2 groups. Twenty-one patients with IDC were classified as New York Heart Association (NYHA) functional class II, 12 as class III, and 2 as class IV. Heart rate was significantly increased in patients with IDC compared with the controls. The plasma concentrations of NE and BNP were higher in the IDC patients, all of whom were free of overt congestive heart failure at the start of this study. The calibrated PMCI was significantly lower in the IDC patients than in the control subjects. Twenty-six patients with IDC were treated with spironolactone, 11 with digitalis, 6 with angiotensin-converting enzyme inhibitors, 28 with angiotensin II type 1 receptor blockers, and 33 with -blockers. Fig 1 shows the typical patterns of myocardial enhancement using MCE. Myocardial contrast in a representative IDC patient was reduced globally, whereas in the control there was good myocardial opacification. The calibrated PMCI was -16.1 dB in the control subject and -27.8 dB in the IDC patient.
Representative Cases of Intravenous Myocardial Contrast Echocardiography
Relationships Among Calibrated PMCI, LV Function and Thallium-201 Myocardial Perfusion Abnormalities in Patients With IDC
There was a close relation between the calibrated PMCI and LVEF in patients with IDC (r=0.688, p<0.0001) (Fig 2A) . In addition, the calibrated PMCI correlated well with the ES using thallium-201 scintigraphy (r=0.539, p=0.0008) (Fig 2B) .
Comparison of Clinical Characteristics Between IDC Patients Subdivided by the Median Value of Calibrated PMCI
We subdivided the IDC patients into 2 groups on the basis of the median value of calibrated PMCI: calibrated PMCI ≥ -22.7 dB (the high-value group; n=17) and calibrated PMCI < -22.7 dB (the low-value group; n=18). Table 2 shows the clinical characteristics of the 2 groups. In the low-value group, there were significant increases in NYHA functional class, LV volume, plasma BNP concentration and ES compared with the high-value group. In addition, systolic blood pressure and LVEF in the lowvalue group were both significantly lower than in the highvalue group. There was no difference in medical therapy between the 2 groups.
Impact of Myocardial Microvascular Integrity on EventFree Survival in Patients With IDC
During the follow-up period (mean 14±4 months), 8 patients had major cardiac events: sudden cardiac death in 
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2 and hospitalization from the progression of heart failure for 6 patients. Univariate and multivariate analyses of the predictors of cardiac events in patients with IDC are shown in Table 3 . Plasma BNP concentration, LVEF and calibrated PMCI were significantly associated with cardiac events in IDC patients (p<0.05 for all). According to a stepwise multivariate analysis, plasma BNP concentration and calibrated PMCI were powerful predictors for cardiac events in IDC patients. There was an association between the calibrated PMCI and cardiac events in patients with IDC with Kaplan-Meier analysis (Fig 3) . The event-free survival rate was markedly lower in the low-value group than in the high-value group (p<0.01).
Discussion
This is the first clinical investigation to use a new echocardiographic technique, MCE, to assess myocardial blood volume in patients with IDC. We demonstrated significant reductions in calibrated PMCI in patients with IDC and also found a close relationship between a reduced calibrated PMCI and LV dysfunction in IDC patients. Furthermore, we found that the calibrated PMCI is a powerful predictor for future cardiac events in these patients.
Myocardial Blood Volume Abnormalities in IDC
The results of previous studies have suggested that myocardial microvascular impairment contributes to LV dysfunction in IDC patients, 15, 16 and positron emission tomography has also revealed evidence of depressed myocardial perfusion in IDC patients. 17, 18 Recent advances in contrast agents and ultrasound technology have enabled us to assess the pathophysiological conditions of the coronary microcirculation using MCE. 19 A recent study has demonstrated that MCE-derived PMCI is a potent variable for evaluating myocardial microvascular and capillary density in ischemic dysfunctional hearts. 20 In the present study, we first investigated myocardial blood volume in IDC patients using MCE, confirming that the calibrated PMCI was significantly reduced in such patients. In addition, a reduced calibrated PMCI was well correlated with a reduced LVEF in the IDC patients, suggesting that the severe microvascular blood volume abnormalities were associated with LV systolic function. In view of our findings, we consider that the calibrated PMCI is a new and useful echocardiographic parameter for the identification of myocardial blood volume in patients with IDC. We also suggest that alterations to the myocardial microvascular may be closely related to LV systolic performance in IDC.
Relation Between the Calibrated PMCI and Cardiac Events in Patients With IDC
The prognostic role of BNP and NE has been well established in patients with heart failure. 21, 22 Recently, scintigraphic studies using thallium-201 or iodine-123-metaiodobenzylguanidine imaging have shown that abnormalities of myocardial perfusion and sympathetic nervous activity provide important information for predicting the outcome in patients with IDC. 23, 24 The present study also demonstrated that high BNP concentrations are associated with increased cardiac events in patients with IDC who have been already treated with standard medical therapy. The most striking finding of this study is that the calibrated PMCI is a powerful predictor for future cardiac events in patients with IDC. Patients with a low value for the calibrated PMCI showed an increased risk of cardiac events despite optimal drug therapy. This result is consistent with the hypothesis that altered microvascular perfusion plays an important role in the occurrence of future cardiac events in patients with IDC. Therefore, our study presents new and interesting information about the microcirculatory conditions in IDC.
Study Limitations
One limitation is that we did not have histological confirmation of the myocardial microvascular alterations in patients with IDC. Further studies are required to evaluate the relation between histological myocardial microvascular abnormalities and MCE parameters in patients with IDC. Another limitation is that we can not completely exclude the variability of myocardial contrast among patients or different myocardial segments. Recently, it has been suggested that the calibration between the regional microvascular integrity and the contrast intensity of the adjacent LV is a useful method for minimizing such variable effects. 10, 11 The development of contrast agents and ultrasound technology, and the advanced knowledge of the bio-effects of microbubbles, enable more accurate evaluation of myocardial microvascular damage in humans.
Conclusion
We demonstrated the myocardial blood volume in IDC patients using a new echocardiographic technique, and clarified the significant relation of a reduced calibrated PMCI to a reduced LVEF and increased risk of cardiac events in patients with IDC. Our study provides useful information about how progressive microvascular alterations may be closely related to LV dysfunction and future cardiac events in IDC.
